MabCure, Inc.
MBCI
$0.0001
$0.000.00%
OTC PK
| 12/31/2011 | 09/30/2011 | 06/30/2011 | 03/31/2011 | 12/31/2010 | |
|---|---|---|---|---|---|
| Revenue | 500.00K | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 500.00K | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 500.00K | -- | -- | -- | -- |
| SG&A Expenses | 197.40K | 169.00K | 187.60K | 280.50K | 145.70K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 273.40K | 266.60K | 318.90K | 349.90K | 241.00K |
| Operating Income | 226.60K | -266.60K | -318.90K | -349.90K | -241.00K |
| Income Before Tax | -11.18M | -275.60K | -411.60K | -394.40K | -243.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.18M | -275.60K | -411.60K | -394.40K | -243.10K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.18M | -275.60K | -411.60K | -394.40K | -243.10K |
| EBIT | 226.60K | -266.60K | -318.90K | -349.90K | -241.00K |
| EBITDA | 231.00K | -259.00K | -309.60K | -338.70K | -230.60K |
| EPS Basic | -0.17 | 0.00 | -0.01 | -0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.17 | 0.00 | -0.01 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 63.96M | 63.47M | 63.12M | 62.84M | 62.40M |
| Average Diluted Shares Outstanding | 63.96M | 63.47M | 63.12M | 62.84M | 62.40M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |